New York, other states urge FDA to expand access to abortion pill
Mifepristone, together with the drug misoprostol, won FDA approval in 2000 for medication abortion in the first 10 weeks of pregnancy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
FDA shuts 3 food businesses at Patradevi, Margao
Panaji: The food and drugs administration (FDA) directed two food business operators—a restaurant and a cashew shop—to suspend operations at Patradevi, Pernem, due to unhygienic conditions. The FDA inspected 18 outlets at Patradevi, issued improvement notices, and gave them 14 days to comply. They seized Rs 50,000 worth of food items, including chips, chocolates, and dry fruits with artificial colours. Samples of sweets were also taken for testing. The FDA also directed a restaurant in Margao to shut down for failing to pay a fine and for non-compliance with FDA directions following its inspection on April 28. They found that only 5 of 30 deficiencies were addressed and ordered the food operator to stop all activities and submit a compliance report. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
Hans India
8 hours ago
- Hans India
Alzheimer's gene therapy shows promise to prevent brain damage
New Delhi: A novel gene therapy for Alzheimer's disease, which showed promise to protect the brain from damage and preserve cognitive function, has renewed hope for millions of patients with the neurodegenerative disease. Worldwide, approximately 57 million people live with dementia, and Alzheimer's disease is the most common cause, accounting for 60-70 per cent of cases. Alzheimer's occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and memory. While current treatments can manage symptoms of Alzheimer's, the new gene therapy aims to halt or even reverse disease progression, said researchers from the University of California San Diego School of Medicine. They noted that, unlike existing treatments for Alzheimer's that target unhealthy protein deposits in the brain, the new approach could help address the root cause of Alzheimer's disease by influencing the behaviour of brain cells themselves. The study investigated the effect of hippocampal SynCav1 delivery in two distinct preclinical mice models. The results, published in the journal Signal Transduction and Targeted Therapy, showed that delivering the treatment at the symptomatic stage of the disease preserved hippocampal-dependent memory -- a critical aspect of cognitive function that is often impaired in Alzheimer's patients. Further, the finding stated that compared to healthy mice of the same age, the treated mice also had a similar pattern of gene expression. This suggests that the treatment has the potential to alter the behaviour of diseased cells to restore them to a healthier state. 'While multiple newly FDA-approved treatments focus on targeting amyloid-beta clearance in Alzheimer's patients, the therapeutic value of SynCav1 lies in its ability to protect vulnerable neurons and augment cellular responses -- mechanisms that differ from currently approved therapies,' said the researchers in the paper. Due to the multitude of neurotoxicity in the Alzheimer's brain, the team called for further studies to investigate SynCav1's therapeutic role when combined with amyloid-targeted drugs to enhance clinical outcomes.
Time of India
a day ago
- Time of India
FDA shuts two eateries, ice factory over hygiene violations
Panaji: The directorate of food and drugs administration (FDA) closed two eateries in Assagao for operating in unhygienic conditions. The first one sold momos, and the other sold biryani. Tired of too many ads? go ad free now Janta Ice Factory at Assagao, operating without an FDA licence, was directed to suspend operations and other premises were issued improvement notices. During the inspection, the FDA fined Ms Zaiqua Rs 10,000 and Ms Bobby Fast Food Rs 8,000 operating at Alankar, Mapusa, for violating norms under the Food Safety Act 2006. The FDA found most premises compliant with norms at Alankar. The inspection team, led by FDA director Shweta Dessai, included designated officer North Goa Richard Noronha, Rajaram Patil, Amit Mandrekar, Nousin Mulla, and Sneha Gaude.
